The headline of this release needs two additional words: “in pigs.”
However, the story reports mainly from news releases, misses some important study limitations, and doesn’t include independent voices.
The news release is very clear that this is an observational study with several limitations.
When it comes to an up-and-coming procedure like this, it’s buyer beware.
One of the studies enrolled just 33 patients, but 10 of those did not have an adequate response to the device. Final results aren’t available from the other study mentioned.
The story does well in giving some background regarding stem cells, and highlighting how this is a growing trend with not a lot of evidence.
The problems with this release lie in what it does not say. Readers aren’t told, for example, that the compound hasn’t even been tested in animals yet.
The story did a good job describing the study, the potential harms of the intervention, and limitations to the findings.